Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Claudia, Bartolini"'
Autor:
Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Marco Bonaso, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: The disease activity associated with the drug-utilization patterns of biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) is poorly investigated in real-world studies on rheumatoid arthritis (RA) patients. To investigate the relati
Externí odkaz:
https://doaj.org/article/0dd20fd9428f4f9aaf484373d027b0bb
Autor:
Carlos E. Durán, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibánez, Mònica Sabaté, Xavier Vidal, Elena Ballarín, Gabriel Sanfélix-Gimeno, Clara Rodríguez-Bernal, Salvador Peiró, Aníbal García-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brøgger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women.Objective: To measure the impact of the 2018 revis
Externí odkaz:
https://doaj.org/article/97c75f28f2b14a79838ac1ce448b894e
Autor:
Claudia Bartolini, Giuseppe Roberto, Anna Girardi, Valentino Moscatelli, Andrea Spini, Alessandro Barchielli, Monica Bocchia, Alberto Fabbri, Sandra Donnini, Marina Ziche, Maria Cristina Monti, Rosa Gini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionItalian administrative healthcare databases are frequently used for studies on real-world drug utilization. However, there is currently a lack of evidence on the accuracy of administrative data in describing the use of infusive antineopla
Externí odkaz:
https://doaj.org/article/65cf1928949b46bdbc224853dba25098
Autor:
Irma Convertino, Massimiliano Cazzato, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Silvia Tillati, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Validation of algorithms for selecting patients from healthcare administrative databases (HAD) is recommended. This PATHFINDER study section is aimed at testing algorithms to select rheumatoid arthritis (RA) patients from Tuscan HAD (THAD) a
Externí odkaz:
https://doaj.org/article/c5ed7e6dd95445e2ad6db8ad78374388
Autor:
Fabio Angeli, Gianpaolo Reboldi, Francesco Giuseppe Solano, Antonietta Prosciutto, Antonella Paolini, Martina Zappa, Claudia Bartolini, Andrea Santucci, Stefano Coiro, Paolo Verdecchia
Publikováno v:
Diagnostics, Vol 13, Iss 9, p 1601 (2023)
Several outcome-based prospective investigations have provided solid data which support the prognostic value of 24 h ambulatory blood pressure over and beyond cardiovascular traditional risk factors. Average 24 h, daytime, and nighttime blood pressur
Externí odkaz:
https://doaj.org/article/cd3b8a0cfd274900afc42df5545a52dc
Autor:
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 465 (2023)
This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective. This retrospective coh
Externí odkaz:
https://doaj.org/article/a99c4db821484d31be05aec53e4084f9
Autor:
Giuseppe Roberto, Anna Girardi, Francesco Barone-Adesi, Alessandro Pecere, Valentina Ientile, Claudia Bartolini, Roberto Da Cas, Stefania Spila-Alegiani, Carmen Ferrajolo, Paolo Francesconi, Gianluca Trifirò, Elisabetta Poluzzi, Fabio Baccetti, Rosa Gini
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: To verify whether, in patients on metformin (MET) monotherapy for type 2 diabetes (T2D), the add-on of a dipeptidyl peptidase inhibitor (DPP4i) compared to a sulfonylurea (SU) can delay the time to the subsequent treatment intensification
Externí odkaz:
https://doaj.org/article/83e9864b58da41d5af4436722a78a591
Autor:
Giuseppe Roberto, Francesco Barone-Adesi, Francesco Giorgianni, Valeria Pizzimenti, Carmen Ferrajolo, Michele Tari, Claudia Bartolini, Roberto Da Cas, Marina Maggini, Stefania Spila-Alegiani, Paolo Francesconi, Gianluca Trifirò, Elisabetta Poluzzi, Fabio Baccetti, Rosa Gini
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitors (DPP4i) are hypoglycaemic agents licensed for the treatment of type 2 diabetes mellitus (T2DM). Although these drugs possess comparable effi
Externí odkaz:
https://doaj.org/article/04a605883ebf4f0e99f14d8bc520baef
Autor:
Giuseppe Roberto, Andrea Spini, Claudia Bartolini, Valentino Moscatelli, Alessandro Barchielli, Davide Paoletti, Silvano Giorgi, Alberto Fabbri, Monica Bocchia, Sandra Donnini, Rosa Gini, Marina Ziche
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229973 (2020)
PURPOSE:To describe patterns of utilization, survival and infectious events in patients treated with rituximab at the University Hospital of Siena (UHS) to explore the feasibility of combining routinely collected administrative and hospital-pharmacy
Externí odkaz:
https://doaj.org/article/f496c4960b1e47a9aab769b3a9fd8d98
Autor:
Marco Massari, Stefania Spila-Alegiani, Massimo Fabiani, Valeria Belleudi, Gianluca Trifirò, Ursula Kirchmayer, Francesca Romana Poggi, Pamela Mancuso, Francesca Menniti-Ippolito, Rosa Gini, Claudia Bartolini, Olivia Leoni, Michele Ercolanoni, Filippo Da-Re, Stefano Guzzinati, Nicoletta Luxi, Flavia Riccardo, Paolo Giorgi-Rossi
Publikováno v:
Vaccines, Vol 9, Iss 7, p 716 (2021)
To investigate the association of the 2019–2020 influenza vaccine with prognosis of patients positive for SARS-CoV-2A, a large multi-database cohort study was conducted in four Italian regions (i.e., Lazio, Lombardy, Veneto, and Tuscany) and the Re
Externí odkaz:
https://doaj.org/article/e307625db8424a638f922e180086519a